Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABA<sub>B</sub>Receptors with Arbaclofen
2012 · Science Translational Medicine · 246 citations
https://doi.org/10.1126/scitranslmed.3004218
P
Peter W. Vanderklish
Century Health(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
4.8K
Citations
37
h-index
56
i10-index
Peter W. Vanderklish is an academic researcher from Century Health. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & RNA Research and Splicing & Calpain Protease Function and Regulation. The author has an h-index of 37, co-authored 58 publications.
ORCID: 0000-0003-1258-1511Papers by this author
worksQuantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in<i>fmr1</i>knockout mice
2008 · Proceedings of the National Academy of Sciences · 164 citations
https://doi.org/10.1073/pnas.0804678105
<i>Fmr1</i> deficiency promotes age-dependent alterations in the cortical synaptic proteome
2015 · Proceedings of the National Academy of Sciences · 83 citations
https://doi.org/10.1073/pnas.1502258112
Differential translation and fragile X syndrome
2005 · Genes Brain & Behavior · 79 citations
https://doi.org/10.1111/j.1601-183x.2005.00134.x
SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease
2021 · Neurotherapeutics · 16 citations
https://doi.org/10.1007/s13311-021-01143-1
Identification of Retinal Amyloid-Beta in Ex Vivo Human Glaucoma Eyes Using a Novel Ocular Tracer
2024 · Journal of Glaucoma · 3 citations
https://doi.org/10.1097/ijg.0000000000002496
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat